Literature DB >> 10959917

Modeling pharmacokinetic data using heavy-tailed multivariate distributions.

J K Lindsey1, B Jones.   

Abstract

Pharmacokinetic studies of drug and metabolite concentrations in the blood are usually conducted as crossover trials, especially in Phases I and II. A longitudinal series of measurements is collected on each subject within each period. Dependence among such observations, within and between periods, will generally be fairly complex, requiring two levels of variance components, for the subjects and for the periods within subjects, and an autocorrelation within periods as well as a time-varying variance. Until now, the standard way in which this has been modeled is using a multivariate normal distribution. Here, we introduce procedures for simultaneously handling these various types of dependence in a wider class of distributions called the multivariate power exponential and Student t families. They can have the heavy tails required for handling the extreme observations that may occur in such contexts. We also consider various forms of serial dependence among the observations and find that they provide more improvement to our models than do the variance components. An integrated Ornstein-Uhlenbeck (IOU) stochastic process fits much better to our data set than the conventional continuous first-order autoregression, CAR(1). We apply these models to a Phase I study of the drug, flosequinan, and its metabolite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959917     DOI: 10.1081/BIP-100102500

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study.

Authors:  Leena Choi; Brian S Caffo; Utkarsh Kohli; Pratik Pandharipande; Daniel Kurnik; E Wesley Ely; C Michael Stein
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-17       Impact factor: 2.745

2.  A strategy for residual error modeling incorporating scedasticity of variance and distribution shape.

Authors:  Anne-Gaëlle Dosne; Martin Bergstrand; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-12-17       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.